entertainment -WSS

entertainment

author：leisure time 2025-08-23 03:45:39 - browse：726

NICOLAS MAETERLINCK/BELGA MAG/AFP via Getty Images

LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of its own.

The French pharma company Sanofi on Friday said it had reached a licensing deal to sell Novavax’s Covid shot going forward as well as to try to combine the vaccine with Sanofi’s own flu shot. The pact includes a $500 million upfront payment, with up to $700 million more on the table if certain regulatory and launch milestones are reached.

While Novavax’s stock soared during the pandemic as the vaccine race was underway, the company failed to get its shot authorized in the U.S. market until July 2022, long after the makers of mRNA vaccines had reaped billions in sales. Sales have sputtered along since then, and last year, the Maryland-based company warned that that it may not be able to stay in business.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Victims of gun violence feel impacts long after bullet wound

focus

WSS

Senate panel clears PBM, hopsital reforms

What is artificial intelligence? Experts weigh in

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

A clever new way to fix Medicaid and graduate medical education

White House calls on federal agencies to crack down on AI abuses

A former Republican legislative candidate has been charged for his role in the US Capitol riot

focus

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A new deal aims to ramp up use of AI in rehab care decisions

Alkermes shareholders re

Hey, doctors: Don't be no

As demand for Covid shots wanes, Moderna seeks its next success

10 million people disenrolled from Medicaid over past six months

Malaria cases in Florida and Texas: Here’s what you need to know

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Drug repurposing or repositioning? The language matters

MoonLake credibility takes another hit with mid

leisure time

STAT Executive Editor Rick Berke on STAT's 8th birthday

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Medicare will require more price transparency from hospitals

Pfizer's RSV vaccine recommended for approval in Europe

10 million people disenrolled from Medicaid over past six months

Wikipedia

leisure time

focus

Wikipedia